Biopharma
Page 1 • 2 itemsGlobal biopharma insights for investors & BD. Track drug development, M&A, and market trends shaping the pharmaceutical landscape.
![NMPA Priority Review Granted to [Drug Name] for Lung Cancer](/uploads/articles/nmpa-priority-review-drugname-lung-cancer-2024.webp)
NMPA Priority Review Granted to [Drug Name] for Lung Cancer
[Drug Name] has received NMPA priority review for lung cancer, potentially revolutionizing patient care and treatment outcomes in this critical area.
![PMDA approves [Drug Name]: Expedited SAKIGAKE approval for [Disease]](/uploads/articles/pmda-approves-[drug-name]-sakigake-[disease]-2024.webp)
PMDA approves [Drug Name]: Expedited SAKIGAKE approval for [Disease]
[Drug Name] has received expedited SAKIGAKE approval from PMDA for the treatment of [Disease], marking a significant advancement in therapeutic options.